Fintel reports that on November 11, 2025, Piper Sandler maintained coverage of 10x Genomics (NasdaqGS:TXG) with a Neutral recommendation.
Analyst Price Forecast Suggests 11.70% Downside
As of November 9, 2025, the average one-year price target for 10x Genomics is $15.08/share. The forecasts range from a low of $12.12 to a high of $17.85. The average price target represents a decrease of 11.70% from its latest reported closing price of $17.08 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for 10x Genomics is 878MM, an increase of 36.78%. The projected annual non-GAAP EPS is -0.58.
What is the Fund Sentiment?
There are 603 funds or institutions reporting positions in 10x Genomics. This is an increase of 76 owner(s) or 14.42% in the last quarter. Average portfolio weight of all funds dedicated to TXG is 0.08%, an increase of 51.48%. Total shares owned by institutions increased in the last three months by 7.40% to 149,345K shares. 
The put/call ratio of TXG is 0.31, indicating a bullish outlook.
What are Other Shareholders Doing?
ARK Investment Management holds 13,892K shares representing 11.93% ownership of the company. In its prior filing, the firm reported owning 12,846K shares , representing an increase of 7.53%. The firm increased its portfolio allocation in TXG by 5.08% over the last quarter.
ARKK - ARK Innovation ETF holds 10,118K shares representing 8.69% ownership of the company. In its prior filing, the firm reported owning 8,711K shares , representing an increase of 13.91%. The firm increased its portfolio allocation in TXG by 19.61% over the last quarter.
Nikko Asset Management Americas holds 6,010K shares representing 5.16% ownership of the company. In its prior filing, the firm reported owning 5,363K shares , representing an increase of 10.77%. The firm increased its portfolio allocation in TXG by 14.92% over the last quarter.
Sumitomo Mitsui Trust Holdings holds 5,381K shares representing 4.62% ownership of the company. In its prior filing, the firm reported owning 6,018K shares , representing a decrease of 11.83%. The firm decreased its portfolio allocation in TXG by 16.64% over the last quarter.
Aqr Capital Management holds 4,138K shares representing 3.55% ownership of the company. In its prior filing, the firm reported owning 1,212K shares , representing an increase of 70.70%. The firm increased its portfolio allocation in TXG by 231.56% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
